Literature DB >> 8920892

Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.

W Held1, D Cado, D H Raulet.   

Abstract

Natural killer (NK) cells and some T cells are endowed with receptors specific for class I major histocompatibility complex (MHC) molecules that can inhibit cellular effector functions. The function of the Ly49 receptor family has been studied in vitro, but no gene transfer experiments have directly established the role of these receptors in NK cell functions. We show here that transgenic expression of the H-2Dd-specific Ly49A receptor in all NK cells and T cells conferred class I-specific inhibition of NK cell-mediated target cell lysis as well as of T cell proliferation. Furthermore, transgene expression prevented NK cell-mediated rejection of allogeneic H-2d bone marrow grafts by irradiated mice. These results demonstrate the function and specificity of Ly49 receptors in vivo, and establish that their subset-specific expression is necessary for the discrimination of MHC-different cells by NK cells in unmanipulated mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920892      PMCID: PMC2192855          DOI: 10.1084/jem.184.5.2037

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

Review 1.  In search of the 'missing self': MHC molecules and NK cell recognition.

Authors:  H G Ljunggren; K Kärre
Journal:  Immunol Today       Date:  1990-07

2.  Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.

Authors:  M Bix; N S Liao; M Zijlstra; J Loring; R Jaenisch; D Raulet
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

Review 3.  Murine natural killer cells and marrow graft rejection.

Authors:  Y Y Yu; V Kumar; M Bennett
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 4.  Receptors for HLA class-I molecules in human natural killer cells.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; R Biassoni; M C Mingari; L Moretta
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice.

Authors:  C Ohlén; G Kling; P Höglund; M Hansson; G Scangos; C Bieberich; G Jay; K Kärre
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

6.  Ly-49 antigen defines an alpha beta TCR population in i-IEL with an extrathymic maturation.

Authors:  J Roland; P A Cazenave
Journal:  Int Immunol       Date:  1992-06       Impact factor: 4.823

7.  Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts.

Authors:  C L Sentman; J Hackett; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

8.  Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.

Authors:  W J Murphy; V Kumar; M Bennett
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses.

Authors:  J M Connolly; T A Potter; E M Wormstall; T H Hansen
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

10.  T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice.

Authors:  H Pircher; T W Mak; R Lang; W Ballhausen; E Rüedi; H Hengartner; R M Zinkernagel; K Bürki
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  21 in total

1.  Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.

Authors:  Anick Chalifour; Joanne Roger; Suzanne Lemieux; Pascale Duplay
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Authors:  A Cambiaggi; C Verthuy; P Naquet; F Romagné; P Ferrier; R Biassoni; A Moretta; L Moretta; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Authors:  Markus Sköld; Martin Stenström; Stephane Sidobre; Petter Höglund; Mitchell Kronenberg; Susanna Cardell
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 4.  Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.

Authors:  Werner Held; Anick Chalifour; Jérôme D Coudert
Journal:  Med Microbiol Immunol       Date:  2005-01-20       Impact factor: 3.402

5.  Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact.

Authors:  Jonathan Back; Anick Chalifour; Léonardo Scarpellino; Werner Held
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

Review 6.  The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.

Authors:  Subramaniam Malarkannan
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

7.  Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.

Authors:  Michael D Bern; Diana L Beckman; Takashi Ebihara; Samantha M Taffner; Jennifer Poursine-Laurent; J Michael White; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

8.  Bone Marrow Cell Rejection, MHC, NK Cells, and Missing Self Recognition: Ain't That Peculiar (with Apologies to Marvin Gaye).

Authors:  David H Raulet
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

9.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

10.  Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.

Authors:  Emily T Durkin; Kelly A Jones; Deepika Rajesh; Aimen F Shaaban
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.